FeesSafety
Pluang+

Coherus Oncology reports Q3 2026 revenue growth and shifts focus to esophageal cancer treatment development.

Company Fundamentals
09 Nov 2026, 23:06 WIB
GlobeNewsWire
View Source
Bullish
Coherus Oncology reports Q3 2026 revenue growth and shifts focus to esophageal cancer treatment development.

Coherus Oncology announced a 25% increase in Q3 2026 revenue to $14 million, driven by growth in sales of its FDA-approved cancer drug LOQTORZI. The company is prioritizing development of tagmokitug/toripalimab for esophageal cancer, aiming for expedited FDA approval, while reducing efforts in other indications and cutting staff by about 30% to improve financial efficiency. Despite a net loss of $38.9 million in Q3, Coherus expects cost reductions to lower cash burn and support a path to financial self-sufficiency. The company plans further clinical studies and regulatory alignment focused on second-line esophageal cancer treatment.

Coherus Oncology's Q3 2026 financial results and strategic plan provide context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 10, 2026 04:11 WIB: out of 150 priced health-sector US stocks, 125 rose and 23 fell today. Among notable movers, TXG (10X Genomics Inc) gained 10.10% to USD 65.27 with a typical hold time of 92 days and a buy order activity of 62%, while DNA (Ginkgo Bioworks Holdings Inc) rose 9.92% to USD 12.41 with a much shorter hold time of 9 days and 100% buy orders. SMMT (Summit Therapeutics Inc) increased 9.61% to USD 17.90 with a 19-day hold time and 98% buy orders.

More News

AmpliTech Group to release Q3 2026 results and hold earnings call on Nov 12

AmpliTech Group to release Q3 2026 results and hold earnings call on Nov 12

AmpliTech Group, a company specializing in RF and microwave components for telecom and defense, will announce its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a conference call at 5:00 PM ET the...

Company Fundamentals
Neutral
55 minutes ago
Toll Brothers opens luxury model homes at Hidden Vista, Palm Desert, starting from $1M

Toll Brothers opens luxury model homes at Hidden Vista, Palm Desert, starting from $1M

Toll Brothers has announced the grand opening of new luxury single-story model homes at Hidden Vista, a gated community in Palm Desert, California, on November 14. These homes offer up to 2,700 sq ft with 3-4 bedrooms, modern open floor plans, and pr...

Market News
Bullish
1 hour ago
FocusReactive tops six major platforms in 2026 for Next.js, headless CMS, and web development excellence.

FocusReactive tops six major platforms in 2026 for Next.js, headless CMS, and web development excellence.

FocusReactive, a web development agency specializing in Next.js and headless CMS, achieved top rankings across six major industry review platforms in 2026, including Clutch, DesignRush, and The Manifest. The agency was recognized globally for experti...

Others
Neutral
2 hours ago
Indonesia's e-commerce market to nearly double to $239.4B by 2032, driven by mobile commerce and live shopping trends.

Indonesia's e-commerce market to nearly double to $239.4B by 2032, driven by mobile commerce and live shopping trends.

Indonesia's e-commerce market is projected to grow from $120.2 billion in 2027 to $239.4 billion by 2032, with a CAGR of 14.78%. Growth is fueled by rising mobile commerce adoption, live-stream shopping, digital payment solutions like PayLater, and e...

Market News
Bullish
2 hours ago
Security National Financial Q3 earnings drop 38.6% amid tough mortgage market and rising rates

Security National Financial Q3 earnings drop 38.6% amid tough mortgage market and rising rates

Security National Financial Corporation reported a 38.6% drop in after-tax earnings for Q3 2026, falling to $6.17 million due to challenging mortgage market conditions and increased interest rates. The mortgage segment faced a $2.65 million loss driv...

Company Fundamentals
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App